FacePhi Biometría S A : Presentation. FacePhi´s webinar - Virtual Roadshow

BME - GROWTH Palacio de la Bolsa Plaza de la Lealtad, 1 28014 Madrid

Alicante, 6th May 2021

COMUNICATION- OTHER RELEVANT INFORMATION - FACEPHI BIOMETRIA, S.A.

Dear Sirs,

Under the provisions of article 17 of the Regulation (EU) No. 596/2014 on market abuse, and article 228 of the consolidated text of the Spanish Securities Market Law, approved by the Royal Legislative Decree 4/2015, of 23rd October, and related provisions, as well as in the Circular 3/2020 of BME Growth, we inform you about the following information related to the company FACEPHI BIOMETRIA, S.A. (hereinafter "FacePhi" or "the Company", interchangeably).

COMUNICATION- OTHER RELEVANT INFORMATION - FACEPHI BIOMETRIA, S.A.

The Company has organized a presentation virtually with the aim of gaining visibility and sharing information of the company with potential investors.

We attach the corporate presentation used in said webinar.

In compliance with Circular 3/2020 of the segment BME Growth of BME MTF Equity, it is expressly stated that the information hereby communicated has been produced under the sole responsibility of the company and its administrators.

We remain at your disposal for any clarification you might deem necessary. Sincerely,

_________________

Salvador Martí Varó

Chairman of the Board of Directors

Page 1

Investors' Presentation

Javier Mira, CEO @FacePhi

© 2021 FacePhi Biometría. All rights reserved. The FacePhi logo and all the trademarks of "FacePhi Biometría S.A." (A-54659313) are registered internationally. The names of other products and companies mentioned herein may be trademarks of their respective owners, for which FacePhi has the corresponding authorisation. As FacePhi frequently introduces new versions and updates of its software, the images shown in this document may differ from those you see on screen.

ConfidentialityDeclaration

This document contains confidential and proprietary information. All data presented is provided on the basis of consent not to use or disclose the information contained herein, except in trade deals with FacePhi Biometría. The recipient of this document agrees to inform all current and future employees and partners who consult or have access to the contents of this document of the confidentiality hereof.

The recipient agrees to give precise instructions to employees not to disclose information relating to this document, except in the case of matters of public knowledge and available for public use. The recipient also agrees not to reproduce or distribute or permit others to reproduce or distribute any material contained herein without the express written consent of FacePhi Biometría.

FacePhi Biometría retains all title, ownership and proprietary rights to the material and trademarks contained herein, including supporting documentation, files, sales and multimedia material.

Acceptance of this document implies that the recipient agrees to be legally bound by the above declaration.

01

Who Are We?

About FacePhi

World leaders in Digital Identity

Biometric and digital onboarding solutions for identity verification.

Sectors:	+90	2020 Revenue
Banking	CLIENTS	€7.2M
Health	+39M
Insurance
	USERS

New clients per year

22

+69%

VS. 2019

13

7

2018 2019 2020

Javier Mira, CEO @FacePhi

Dual-listing

Since 2020

Since 2014

Revaluation	Capitalisation
last 5 years	€56M
647%
30th April 2021

This document contains confidential and proprietary information belonging only to FacePhi©. All data presented is provided on the basis of consent not to use or disclose the information contained herein.